Log in

Aptorum Group Stock Forecast, Price & News

-0.02 (-0.97 %)
(As of 10/28/2020 12:00 AM ET)
Today's Range
Now: $2.04
50-Day Range
MA: $2.22
52-Week Range
Now: $2.04
Volume225,368 shs
Average Volume541,526 shs
Market Capitalization$69.38 million
P/E RatioN/A
Dividend YieldN/A
Aptorum Group Limited, a pharmaceutical company, engages in the discovery, development, and commercialization of therapeutic assets to treat diseases with unmet medical needs, particularly infectious diseases and cancers. Its pipeline through the establishment of drug discovery platforms enable the discovery of new therapeutics assets, such as systematic screening of existing approved drug molecules, and microbiome-based research platform for treatments of metabolic diseases. The company is also pursuing therapeutic and diagnostic projects in neurology, gastroenterology, metabolic disorders, women's health, and other disease areas. It also has projects focused on surgical robotics and natural supplement for women undergoing menopause and experiencing related symptoms. Aptorum Group Limited was incorporated in 2010 and is headquartered in London, the United Kingdom.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.6Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.52 out of 5 stars

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Current SymbolNASDAQ:APM



Sales & Book Value

Annual Sales$540,000.00
Book Value$0.51 per share



Market Cap$69.38 million
Next Earnings DateN/A
OptionableNot Optionable
-0.02 (-0.97 %)
(As of 10/28/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive APM News and Ratings via Email

Sign-up to receive the latest news and ratings for APM and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

Aptorum Group (NASDAQ:APM) Frequently Asked Questions

How has Aptorum Group's stock price been impacted by Coronavirus (COVID-19)?

Aptorum Group's stock was trading at $2.93 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, APM shares have decreased by 30.4% and is now trading at $2.04.
View which stocks have been most impacted by COVID-19

Do Wall Street analysts recommend investors buy shares of Aptorum Group?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Aptorum Group in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Aptorum Group

Are investors shorting Aptorum Group?

Aptorum Group saw a drop in short interest in the month of October. As of October 15th, there was short interest totaling 305,800 shares, a drop of 14.2% from the September 30th total of 356,500 shares. Based on an average trading volume of 1,610,000 shares, the short-interest ratio is presently 0.2 days. Approximately 5.5% of the shares of the company are short sold.
View Aptorum Group's Short Interest

Who are some of Aptorum Group's key competitors?

What other stocks do shareholders of Aptorum Group own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Aptorum Group investors own include Gilead Sciences (GILD), SCYNEXIS (SCYX), Cidara Therapeutics (CDTX), Quest Diagnostics (DGX), Dynavax Technologies (DVAX), Inovio Pharmaceuticals (INO), (MRNA), Micron Technology (MU), Sanofi (SNY) and Aridis Pharmaceuticals (ARDS).

Who are Aptorum Group's key executives?

Aptorum Group's management team includes the following people:
  • Mr. Chung Yuen Huen, Founder, Chairman & CEO (Age 40, Pay $441.79k)
  • Mr. Darren Lui, Pres & Exec. Director (Age 39, Pay $389.79k)
  • Ms. Sabrina Khan, Chief Financial Officer (Age 39, Pay $322.64k)
  • Dr. Siu-yan Ng, Chief Operating Officer (Age 39, Pay $113.99k)
  • Dr. Clark Cheng, Chief Medical Officer & Exec. Director (Age 40, Pay $432.47k)

What is Aptorum Group's stock symbol?

Aptorum Group trades on the NASDAQ under the ticker symbol "APM."

How do I buy shares of Aptorum Group?

Shares of APM can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Aptorum Group's stock price today?

One share of APM stock can currently be purchased for approximately $2.04.

How big of a company is Aptorum Group?

Aptorum Group has a market capitalization of $69.38 million and generates $540,000.00 in revenue each year. Aptorum Group employs 36 workers across the globe.

What is Aptorum Group's official website?

The official website for Aptorum Group is www.aptorumgroup.com.

How can I contact Aptorum Group?

Aptorum Group's mailing address is 17/F GUANGDONG INVESTMENT TOWER 148 CONNAUGHT ROAD CENTRAL, HONG KONG K3, 999077. The company can be reached via phone at 852-2117-6611 or via email at [email protected]

This page was last updated on 10/29/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.